Literature DB >> 10666420

Interferon-gamma induces AT(2) receptor expression in fibroblasts by Jak/STAT pathway and interferon regulatory factor-1.

M Horiuchi1, W Hayashida, M Akishita, S Yamada, J Y Lehtonen, K Tamura, L Daviet, Y E Chen, M Hamai, T X Cui, M Iwai, Y Minokoshi.   

Abstract

The expression of angiotensin II type 2 (AT(2)) receptor is closely associated with cell growth, differentiation, and/or injury. We examined the effect of interferon (IFN)-gamma on AT(2) receptor expression in mouse fibroblast R3T3 cells and demonstrated that IFN-gamma treatment increased the expression of AT(2) receptor mRNA as well as its binding. Interferon regulatory factor (IRF)-1 was induced in mouse fibroblast R3T3 cells after IFN-gamma stimulation, and electrophoretic mobility shift assay showed an increase in IRF-1 binding with the IRF-specific binding sequence in the AT(2) receptor gene promoter region after IFN-gamma stimulation. The IRF-1 gene promoter contains an IFN-gamma-activated sequence (GAS) motif for possible binding of signal transducer(s) and activator(s) of transcription (STAT). Indeed, in R3T3 cells, IFN-gamma treatment resulted in rapid activation of Janus kinase (Jak) 1, Jak2, and STAT1 via tyrosine phosphorylation. Electrophoretic mobility shift assay with the GAS probe revealed increased STAT1 binding to the IRF-1 gene promoter in response to IFN-gamma stimulation. Transfection of GAS-binding oligonucleotides inhibited the effect of IFN-gamma on IRF-1 production, resulting in the AT(2) receptor trans-activation. Taken together, our data show that IFN-gamma upregulates AT(2) receptor expression in R3T3 cells via the activation of the intracellular Jak/STAT pathway and production of IRF-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666420     DOI: 10.1161/01.res.86.2.233

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

Review 1.  The interferon signaling network and transcription factor C/EBP-beta.

Authors:  Hui Li; Padmaja Gade; Weihua Xiao; Dhan V Kalvakolanu
Journal:  Cell Mol Immunol       Date:  2007-12       Impact factor: 11.530

Review 2.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

3.  Interferons in enteroviral heart disease: modulation of cytokine expression and antiviral activity.

Authors:  Albert Heim; Sabine Weiss
Journal:  Med Microbiol Immunol       Date:  2003-09-12       Impact factor: 3.402

Review 4.  JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation.

Authors:  Ryousuke Satou; Romer A Gonzalez-Villalobos
Journal:  JAKSTAT       Date:  2012-10-01

5.  ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation.

Authors:  Youqian Wu; Chao Zhang; Xiaolan Liu; Zhengfu He; Bing Shan; Qingxin Zeng; Qingwei Zhao; Huaying Zhu; Hongwei Liao; Xufeng Cen; Xiaoyan Xu; Mengmeng Zhang; Tingjun Hou; Zhe Wang; Huanhuan Yan; Shuying Yang; Yaqin Sun; Yanying Chen; Ronghai Wu; Tingxue Xie; Wei Chen; Ayaz Najafov; Songmin Ying; Hongguang Xia
Journal:  Nat Commun       Date:  2021-04-20       Impact factor: 14.919

6.  Experimental Study of Antiatherosclerosis Effects with Hederagenin in Rats.

Authors:  Su-Hong Lu; Jian-Hua Guan; Yan-Li Huang; Yu-Wei Pan; Wei Yang; Hai Lan; Si Huang; Jing Hu; Guo-Ping Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

7.  Increased AT2R expression is induced by AT1R autoantibody via two axes, Klf-5/IRF-1 and circErbB4/miR-29a-5p, to promote VSMC migration.

Authors:  Yan Sun; Yang Li; Meili Wang; Mingming Yue; Lina Bai; Jingwei Bian; Weiwei Hao; Jing Sun; Suli Zhang; Huirong Liu
Journal:  Cell Death Dis       Date:  2020-06-08       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.